Spectrofluorimetric determination of SN-38, a promising new anti-tumor agent, in the presence and absence of organized media

Applied Spectroscopy

Volumn 65, Issue 3, 2011, Pages 298-306

  Rodríguez Cáceres, Maria Isabel ^a   Gil, Diego Bohoyo ^b   Durán Merás, Isabel ^a   Sánchez, Maria C Hurtado ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Technological Institute of Food and Agriculture of Extremadura INTAEX   (Spain)

Author keywords

Anti tumor agents; Camptothecin; Cancer; Cyclodextrins; Hp cd; SN 38; Spectrofluorimetry; Surfactants; Urine

Indexed keywords

ANTI-TUMOR AGENTS; CAMPTOTHECIN; CANCER; SN-38; SPECTROFLUORIMETRY; SURFACTANTS; URINE;

CARBOXYLATION; CYCLODEXTRINS; DISEASES; DRUG PRODUCTS; LIQUIDS; SOLVENT EXTRACTION; SURFACE ACTIVE AGENTS; TUMORS;

BODY FLUIDS;

ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CYCLODEXTRIN; DRUG DERIVATIVE; IRINOTECAN; SURFACTANT;

ARTICLE; CHEMISTRY; EVALUATION; HUMAN; METHODOLOGY; SPECTROFLUOROMETRY; URINE;

ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CYCLODEXTRINS; HUMANS; SPECTROMETRY, FLUORESCENCE; SURFACE-ACTIVE AGENTS;

EID: 79952944734     PISSN: 00037028     EISSN: None     Source Type: Journal    
DOI: 10.1366/10-06019     Document Type: Article

References (35)

1. M. E. Wall, M. C. Wani, C. E. Cook, K. H. Palmer, A. T. McPhail, and G. A. Sim, J. Am. Chem. Soc. 88, 3888 (1966).
2. J. Dey and I. M. Warner, J. Photochem. Photobiol. A 101, 21 (1996).
3. D. J. Th. Wagener, H. E. R. Verdonk, L. Y. Dirix, G. Catimel, P. Siegenthaler, M. Buitenhuis, A. Mathieu-Boué, and J. Verweij, Ann. Oncol. 6, 129 (1995).
4. C. H. Takimoto and S. G. Arbuck, "Topoisomerase I targeting agents: the camptothecins", in Cancer Chemotherapy and Biolherapy: Principles and Practice, B. A. Chabner and D. L. Longo, Eds. (Lippincott Williams & Wilkins, Philadelphia, PA, 2001), 3rd ed., pp. 579-646.
5. K. Sai, N. Kaniwa, S. Ozawa, and J. Sawada, Biomed. Chromatogr. 16, 209 (2002).
6. F. A. de Jong, R. H. J. Mathijssen, P. de Bruijn, W. J. Loos, J. Verweij, and A. Sparreboom, J. Chromatogr. B 795, 383 (2003).
7. S. Poujol, F. Pinguet, F. Malosse, C. Astre, M. Ychou, S. Culine, and F. Bressolle, Clin. Chem. 49, 1900 (2003).
8. X. Yang, Z. Hu, S. Y. Chan, B. C. Goh, W. Duan, E. Chan, and S. Zhou, J. Chromatogr. B 821, 221 (2005).
9. S. Ragot, P. Marquet, F. Lachâtre, A. Rousseau, E. Lacassie, J. M. Gaulier, J. L. Dupuy, and G. Lachâtre, J. Chromatogr. B 736, 175 (1999).
10. S. Bardin, W. Guo, J. L. Johnson, S. Khan, A. Ahmad, J. X. Duggan, J. Ayoub, and I. Ahmad, J. Chromatogr. A 1073, 249 (2005).
11. F. D'Esposito, B. N. Tattam, I. Tamzan, and M. Murray, J. Chromatogr. B 875, 522 (2008).
12. N. Kaneda, Y. Hosokawa, and R. Yokokura, Biol. Pharm. Bull. 20, 815 (1997).
13. P. de Bruijn, M. J. A. de Jonge, J. Verweij, W. J. Loos, K. Nooter, G. Stoter, and A. Sparreboom, Anal. Biochem. 269, 174 (1999).
14. L. P. Rivory, M. Findlay, S. Clarke, and J. Bishop, J. Chromatogr. B 714, 355 (1998).
15. R. H. Mathijssen, R. J. van Alphen, J. Verweij, W. J. Loos, K. Nooter, G. Stoter, and A. Sparreboom, Clin. Cancer Res. 7, 2182 (2001).
16. N. Hanioka, H. Jinno, T. Nishimura, M. Ando, S. Ozawa, and J. Sawada, Biomed. Chromatogr. 15, 328 (2001).
17. P. de Bruijn, E. W. Willems, W. J. Loos, J. Verweij, and A. Sparreboom, Anal. Biochem. 328, 84 (2004).
18. S. Khan, A. Ahmad, and I. Ahmad, Biomed. Chromatogr. 17, 493 (2003).
19. W. Guo, A. Ahmad, S. Khan, F. Dahhani, Y. F. Wang, and I. J. Ahmad, Chromatogr. B 791, 85 (2003).
20. S. Khan, A. Ahmad, W. Guo, Y.-F. Wang, A. Abu-Qare, and I. Ahmad, J. Pharm. Biomed. Anal. 37, 135 (2005).
21. C. Foulon, J. Tedou, T. Queruau Lamerie, C. Vaccher, J. P. Bonte, and J. F. Goossens, Tetrahedron: Asymmetry 20, 2482 (2009).
22. J. Kang, V. Kumar, D. Yang, P. R. Chowhury, and R. J. Hohl, Eur. J. Pharm. Sci. 15, 163 (2002).
23. Y. Matsumura, Drugs Fut. 34, 276 (2009).
24. www.Clinical Trial. org, Identifier NCT00542958.
25. www.Clinical Trial. org, Identifier NTC00951613.
26. www.Clinical Trial. org, Identifier NCT00951054.
27. J. Fassberg and V. J. Stella, J. Pharm. Sci. 81, 676 (1992).
28. W. Stenström and N. Goldsmith, J. Phys. Chem. 30, 1683 (1926).
29. R. F. Wilson and G. W. Lester, Talanta 10, 319 (1963).
30. H. Benesi and J. J. Hildebrand, Am. Chem. Soc. 71, 2703 (1949).
31. G. L. Long and J. D. Winefordner, Anal. Chem. 55, 712A (1983).
32. C. A. Clayton, J. W. Hines, and P. D. Elkins, Anal. Chem. 59, 2506 (1987).
33. IUPAC, Analytical Chemistry Division, Spectrochim. Acta, Part B 33, 241 (1978).
34. R. H. J. Mathijssen, T. J. van Alphen, J. Verweij, W. J. Loos, K. Nooter, G. Stoter, and A. Sparreboom, Clin. Cancer Res. 7, 2182 (2001).
35. D. C. Baquiran, Cancer Chemotherapy Handbook (Lippincott, Philadelphia, PA, 2001), 2nd ed.